MedTrace Logo

Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease

NCT01835691 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2017-10-19

No results posted yet for this study

Summary

This study is to research two questions. First, is vitamin D3 more effective than vitamin D2 in raising 25-hydroxyvitamin D \[25(OH)D\] levels in chronic kidney disease (CKD) patients? And secondly, what are the differential effects of vitamin D2 and vitamin D3 on other mineral metabolism parameters?

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D2 (ergocalciferol)

50,000 units once a week for 12 weeks

DIETARY_SUPPLEMENT

Vitamin D3 (cholecalciferol)

50,000 units once a week for 12 weeks

Sponsors & Collaborators

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Jason Stubbs, MD · University of Kansas Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01835691 on ClinicalTrials.gov